Search results for "Probability."

showing 10 items of 3396 documents

Animacy-based predictions in language comprehension are robust: contextual cues modulate but do not nullify them

2015

Couldn't a humble coconut hurt a gardener? At least in the first instance, the brain seems to assume that it should not: we perceive inanimate entities such as coconuts as poor event instigators ("Actors"). Ideally, entities causing a change in another entity should be animate and this assumption not only influences event perception but also carries over to language comprehension. We present three auditory event-related brain potential (ERP) studies on the processing of inanimate and animate subjects and objects in simple transitive sentences in Tamil. ERP responses were measured at the second argument (event participant) in all three studies. Experiment 1 employed all possible animacy comb…

AdultMaleTamilTime Factorsanimacypredictive processingContext (language use)VocabularySentence processingJudgmentYoung AdultArgumentSurveys and QuestionnairesHumansEvoked PotentialsMolecular BiologyLanguageEvent (probability theory)Analysis of VarianceTransitive relationCommunicationbusiness.industryGeneral NeuroscienceBrainElectroencephalographysentence processingcontextual cuesERPslanguage.human_languageComprehensionAcoustic StimulationTamillanguageFemaleNeurology (clinical)CuesComprehensionAnimacyPsychologybusinessDevelopmental BiologyCognitive psychologyactor
researchProduct

Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma

2000

A consecutive series of 63 untreated patients undergoing surgical resection for stage I-IV gastric adenocarcinomas (GCs) has been prospectively studied. Our purpose was to analyze the predictive relevance of DNA ploidy, S-phase fraction (SPF), and tissue levels of lysosomal proteinases cathepsin D (CD), cathepsin B (CB), cathepsin L (CL), and urokinase-type plasminogen activator (uPA) and that of the intracellular cysteine proteinase inhibitor stefin A on clinical outcome. All of the patients taking part in this study were followed up for a median of 73 months. DNA aneuploidy was present in 71% of the cases (45/63), whereas 9% of these (4/45) showed multiclonality. Both DNA ploidy and SPF w…

AdultMaleTime FactorsAdenocarcinomaS PhasePredictive Value of TestsStomach NeoplasmsBiomarkers TumorAspartic Acid EndopeptidasesHumansNeoplasm Invasivenesshumancell cycle S phase; disease association; female; histopathology; human; lymph node metastasisAgedProbabilityPloidieslymph node metastasisdisease associationSerine EndopeptidasesDNA NeoplasmMiddle AgedPrognosisSurvival AnalysisCysteine Endopeptidasescell cycle S phaseLymphatic MetastasishistopathologyFemaleFollow-Up Studies
researchProduct

Addition of a second opioid may improve opioid response in cancer pain: preliminary data

2004

Recent experimental data suggest a possible use of an opioid combination to improve analgesia. In cancer patients, a rapid opioid escalation due to either worsening of the pain condition or the development of tolerance is a critical phase, as this condition is associated with a negative prognosis. The aim of this study was to assess the effects of adding a second opioid at low doses in patients with a poor analgesic benefit after dose escalation. Fourteen patients receiving strong opioids who had increased their dosage more than 100% in the last week unsuccessfully were randomly chosen to add a second opioid to the first using an initial equivalent dosage of 20% of the previous therapy. The…

AdultMalecancer painMaximum Tolerated DosePain medicineAnalgesicPainRisk AssessmentSeverity of Illness IndexDrug Administration ScheduleStatistics Nonparametriclaw.inventionPharmacotherapyRandomized controlled triallawNeoplasmsMedicineHumansTerminally IllProspective StudiesKarnofsky Performance StatusAdverse effectAgedPain MeasurementProbabilityTerminal CareDose-Response Relationship DrugMorphinebusiness.industryMiddle AgedClinical trialAnalgesics OpioidFentanylTreatment OutcomeOncologyOpioidopioid responseAnesthesiaopioid treatmentDrug Therapy CombinationFemaleCancer painbusinessmedicine.drug
researchProduct

Requestioning depression in patients with cancer: Contribution of somatic and affective symptoms to Beck's Depression Inventory

2007

Background: Depressive symptoms are a major complaint reported by cancer patients. Somatic and affective symptoms can contribute to depression. Patients and methods: We investigated the prevalence of somatic and affective depressive symptoms with the Beck Depression Inventory (BDI) in 213 hospitalized cancer patients prior to the start of chemotherapy. Results: Seventeen of 213 patients (8%) were screened positive for major depression; 40 (19%) had mild to moderate depressive symptoms. The corresponding figures for somatic and affective symptoms were 33.3% and 2.8% in the patients with major depression and 23.0% and 8.0% in those with mild to moderate depressive symptoms. Female patients, p…

AdultMalemedicine.medical_specialtyAdolescentComorbidityRisk AssessmentStatistics NonparametricHospitals UniversityAge DistributionQuality of lifeGermanyNeoplasmsSickness Impact ProfileSurveys and QuestionnairesInternal medicineAdaptation PsychologicalInterview PsychologicalPrevalencemedicineHumansSex DistributionPsychiatryDepression (differential diagnoses)AgedProbabilityPsychiatric Status Rating ScalesDepressive Disorderbusiness.industryCase-control studyBeck Depression InventoryCancerHematologyMiddle Agedmedicine.diseaseComorbidityChemotherapy regimenCausalityOncologyCase-Control StudiesQuality of LifeMajor depressive disorderFemalebusinessStress PsychologicalFollow-Up StudiesAnnals of Oncology
researchProduct

Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a …

2007

Abstract Background To compare the efficacy and safety of three different chemotherapy doublets in the treatment of advanced pancreatic cancer (PC). Patients and methods At total of 190 patients were randomly assigned to receive capecitabine 1000 mg/m2 twice daily on days 1–14 plus oxaliplatin 130 mg/m2 on day 1 (CapOx), capecitabine 825 mg/m2 twice daily on days 1–14 plus gemcitabine 1000 mg/m2 on days 1 and 8 (CapGem) or gemcitabine 1000 mg/m2 on days 1 and 8 plus oxaliplatin 130 mg/m2 on day 8 (mGemOx). Treatment cycles were repeated every three weeks. The primary end point was progression-free survival (PFS) rate at 3 months; secondary end points included objective response rate, carboh…

AdultMalemedicine.medical_specialtyAdolescentMaximum Tolerated DoseOrganoplatinum CompoundsPhases of clinical researchKaplan-Meier EstimateDeoxycytidineRisk AssessmentGastroenterologyDisease-Free SurvivalDrug Administration ScheduleCapecitabineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansSingle-Blind MethodProgression-free survivalInfusions IntravenousCapecitabineAgedNeoplasm StagingProbabilityDose-Response Relationship Drugbusiness.industryCAPOX RegimenHematologyMiddle AgedImmunohistochemistrySurvival AnalysisGemcitabineGemcitabineOxaliplatinSurgeryOxaliplatinPancreatic NeoplasmsRegimenTreatment OutcomeOncologyTolerabilityFemaleFluorouracilbusinessFollow-Up Studiesmedicine.drugAnnals of Oncology
researchProduct

Predictors of functional outcome after a manic episode.

2015

Abstract Background The identification of functional outcome predictors after acute episodes of bipolar disorders (BD) may allow designing appropriate treatment aiming at restoring psychosocial functioning. Our objective was to identify the best functional outcome predictors at a 6-month follow-up after an index manic episode. Methods We conducted a naturalistic trial (MANACOR) focusing on the global burden of BD, with special emphasis on manic episode-associated costs. We observed patients with BD seen in services of four hospitals in Catalonia (Spain).The total sample included 169 patients with chronic DSM-IV-TR BD I suffering from an acute manic episode who were followed-up for 6 months.…

AdultMalemedicine.medical_specialtyBipolar DisorderBody Mass IndexRecurrenceInternal medicinemedicineHumansBipolar disorderPsychiatryRetrospective StudiesStepwise regressionmedicine.diseaseOutcome (probability)Psychiatry and Mental healthClinical PsychologyTreatment OutcomeSocioeconomic FactorsSpainTreatment strategyFemalePredictive variablesPsychologyPsychosocialBody mass indexFollow-Up StudiesJournal of affective disorders
researchProduct

Acute stress impairs reward positivity effect in probabilistic learning

2019

Decision making based on feedback learning requires a series of cognitive processes, including estimating the probability of particular outcomes and modulating expectations between expected versus actual outcomes. It has been suggested that stress affects decision making and subsequent processing of feedback valence and magnitude. However, less is known about the effect of acute stress on reward expectancy. In the current study, participants performed a probabilistic learning task, in which they learned an association between response and feedback within different reward expectancy trials (30% and 70%) under the conditions of stress (threat of shock) and safety (no shock). We recorded event…

AdultMalemedicine.medical_specialtyCognitive NeuroscienceExperimental and Cognitive PsychologyAudiology050105 experimental psychologyCorrelationYoung Adult03 medical and health sciences0302 clinical medicineRewardDevelopmental NeurosciencemedicineHumansReinforcement learningAttention0501 psychology and cognitive sciencesAcute stressValence (psychology)Positivity effectEvoked PotentialsBiological PsychiatryExpectancy theoryEndocrine and Autonomic SystemsGeneral Neuroscience05 social sciencesProbabilistic logicAssociation LearningCognitionAnticipation PsychologicalNeuropsychology and Physiological PsychologyNeurologyFemaleProbability LearningPsychologyPsychomotor PerformanceStress Psychologicalpsychological phenomena and processes030217 neurology & neurosurgeryPsychophysiology
researchProduct

The diagnostic performance of renal function-adjusted D-dimer testing in individuals suspected of having venous thromboembolism

2019

Renal impairment, a source of chronic hypercoagulability[1][1] and inflammation,[2][2] is known to reduce the specificity of the D-dimer test in the diagnosis of venous thromboembolism (VTE).[3][3] This leads to many false positives in such patients and consequently to additional costs, as well as

AdultMalemedicine.medical_specialtyComputed Tomography AngiographyRenal functionSensitivity and SpecificityFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineText miningInternal medicineD-dimermedicineFalse positive paradoxHumansFalse Positive ReactionsProspective StudiesRenal InsufficiencyProspective cohort studyOnline Only ArticlesComputed tomography angiographyAgedProbabilityVenous Thrombosismedicine.diagnostic_testbusiness.industryHematologyVenous ThromboembolismMiddle AgedCardiologyFemalebusinessPulmonary EmbolismVenous thromboembolismAlgorithms030215 immunologyGlomerular Filtration RateHaematologica-the Hematology Journal
researchProduct

Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Inst…

2018

: Recommended strategy for venous thromboembolism (VTE) diagnosis includes the use of sensitive D-dimer (DDi) assays along with pretest probability (PTP) assessment. The Clinical and Laboratory Standards Institute (CLSI) recently issued a guideline (US FDA endorsed) on DDi in VTE exclusion. Such guideline specifies the ideal D-dimer assay characteristics and target population. Demonstrate STA-LiatestD-Di performance combined with a PTP score for proximal deep vein thrombosis (pDVT) exclusion in a CLSI compliant study. International, multicenter, prospective nonrandomized, noninterventional clinical outcome management study conducted in a standard-of-care setting. DDi was measured in DVT-sus…

AdultMalemedicine.medical_specialtyDeep veinShort Communications030204 cardiovascular system & hematologySensitivity and SpecificityFibrin Fibrinogen Degradation ProductsSTA-Liatest DDi03 medical and health sciences0302 clinical medicineInternal medicineOutpatientsD-dimermedicineHumansProspective StudiesProspective cohort studyexclusiondeep venous thrombosisAgedVenous ThrombosisUnited States Food and Drug Administrationbusiness.industryImmunoturbidimetryHematologyGeneral MedicineGuidelineMiddle Agedmedicine.diseaseThrombosisUnited StatesPulmonary embolismClinical trialPre- and post-test probabilitymedicine.anatomical_structureD-dimerFemalebusiness030215 immunologyBlood Coagulation & Fibrinolysis
researchProduct

Survival and tissue maintenance of an implant with a sloped configurated shoulder in the posterior mandible-a prospective multicenter study.

2016

Aim Clinical studies evaluating the influence of the implant design on the preservation of peri-implant keratinized mucosa are rare. The aim of this prospective multicenter study was to investigate the survival, and soft and hard tissue maintenance of an implant with a sloped shoulder configuration, when placed in the posterior mandible. Material and Methods In this study, 24 centers participated and 184 patients receiving 238 implants (OsseoSpeed™ Profile TX implants) were included. Clinical assessments of soft tissue parameters were performed before implant placement, immediately after implant placement, at prosthetic delivery and at 6, 12 and 24 months after implant placement and margina…

AdultMalemedicine.medical_specialtyDentistryMandible01 natural sciences010104 statistics & probability03 medical and health sciences0302 clinical medicinemedicineAlveolar ProcessHumansProspective Studies0101 mathematicsProspective cohort studySurvival rateSurvival analysisAgedAged 80 and overDental Implantsbusiness.industryAlveolar processMandibleMouth MucosaSoft tissue030206 dentistryMiddle AgedSurvival AnalysisSurgerymedicine.anatomical_structureMulticenter studyDental Prosthesis DesignTooth ExtractionKeratinsFemaleImplantOral SurgerybusinessClinical oral implants research
researchProduct